Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Integrin stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Preclinical | US | 16 Sep 2020 | |
Muscular Dystrophies, Limb-Girdle | Preclinical | US | 09 Sep 2020 |